Therapeutic Effects of Anti-Bone Morphogenetic Protein and Activin Membrane-Bound Inhibitor Treatment in Psoriasis and Arthritis.
Pilar AlvarezJuan Jesús AugustínEsther TamayoMarcos IglesiasOlga AcinasMaría Angeles MendigurenJosé Andrés VázquezFernanda GenreDavid San SegundoJesús MerinoRamón MerinoPublished in: Arthritis & rheumatology (Hoboken, N.J.) (2020)
These results in murine models identify BAMBI as a promising new therapeutic target for chronic inflammatory diseases and other pathologic conditions modulated by Treg cells.